Abstract #2189
Assessment of Response to Anti-angiogenic Targeted Therapy in Pulmonary Metastatic Renal Cell Carcinoma R2 value as a Predictive Biomarker
Guangyu Wu 1 and Jianrong Xu 1
1
Department of Radiology, Renji Hospital,
Shanghai Jiao Tong University School of Medicine,
, ΟΊ, China
This study was to evaluate the usefulness of magnetic
resonance(MR) R2* mapping in assessing response of
treatment in patients with pulmonary metastatic renal
cell carcinoma receiving anti-angiogenic targeted
therapy.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
